36-482-Hyaluronoglucosaminidase PH20 (rHuPH20) ( DrugBank: Hyaluronoglucosaminidase )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
65	原発性免疫不全症候群	1

65. 原発性免疫不全症候群

臨床試験数 : 482 / 薬物数 : 653 - (DrugBank : 119) / 標的遺伝子数 : 92 - 標的パスウェイ数 : 212

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2012-000481-38-GB (EUCTR)	28/06/2012	26/04/2012	Assessment of the safety of Immunoglobulin and recombinant human hylaluronidase in the treatment of ...	Tolerability, Safety and Product Administration Evaluation of rHuPH20 Facilitated Subcutaneous Treat ...	Primary Immunodeficiency Diseases MedDRA version: 14.1;Level: HLT;Classification code 10036700;Term: ...	Trade Name: KIOVIG 100 mg/ml solution for infusion Product Name: Human normal immunoglobulin INN or Pr ...	Baxter Innovations GmbH	NULL	Not Recruiting			Female: yes Male: yes	40		Czech Republic;Belgium;Netherlands;Germany;Switzerland;Italy;United Kingdom;Sweden

First Previous1Next Last